# A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects

> **NCT02111252** · PHASE1,PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 55 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** TAK-850

## Key facts

- **NCT ID:** NCT02111252
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2015-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111252, "A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02111252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*